GoDaddy Founder Bob Parsons on Psychedelics and PTSD: Part One
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about his time in Vietnam, PTSD, and his healing journey with psychedelics
GoDaddy Founder Bob Parsons talks to Psychedelic Spotlight about his time in Vietnam, PTSD, and his healing journey with psychedelics
Can wearable technology help alleviate stress? Apollo Neuro’s new wearable shows amazing promise
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
Jon Stewart, comedian and former host of “The Daily Show,” drops a shroom bomb in a recent podcast interview.
Have you ever considered taking 5-MeO-DMT, also known as Bufo…
Microdosing psychedelics is more popular than ever, but is there any evidence that it works? We unpack the great microdosing debate.
In this episode, Dr. Khamsehzadeh delves into our historical and ancestral relationship to psilocybin and theorizes how mushrooms have impacted the development of the brain.
There is growing interest in AI’s ability to mimic human interactions. We interview OpenAI’s GPT-3 chatbot to see what it knows about psychedelics.
Ketamine therapy is shaping up to be one of the…
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.